18F-THK5351 PET Findings Indicative of Reactive Astrogliosis in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy

Gen Yoshii, Keiko Hatano, Masashi Kameyama, Atsushi Iwata

Open source

DOI
10.1097/rlu.0000000000006641
Published
2026-09-24
Container
Clinical Nuclear Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/rlu.0000000000006641,
  title = {18F-THK5351 PET Findings Indicative of Reactive Astrogliosis in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy},
  author = {Gen Yoshii and Keiko Hatano and Masashi Kameyama and Atsushi Iwata},
  year = {2026},
  journal = {Clinical Nuclear Medicine},
  doi = {10.1097/rlu.0000000000006641},
  url = {https://doi.org/10.1097/rlu.0000000000006641}
}

RIS

TY  - JOUR
TI  - 18F-THK5351 PET Findings Indicative of Reactive Astrogliosis in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
AU  - Gen Yoshii
AU  - Keiko Hatano
AU  - Masashi Kameyama
AU  - Atsushi Iwata
PY  - 2026
JO  - Clinical Nuclear Medicine
DO  - 10.1097/rlu.0000000000006641
UR  - https://doi.org/10.1097/rlu.0000000000006641
ER  - 

APA

Yoshii, G., Hatano, K., Kameyama, M., & Iwata, A. (2026). 18F-THK5351 PET Findings Indicative of Reactive Astrogliosis in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000006641

Source records